SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027488
Filing Date
2016-11-04
Accepted
2016-11-03 21:20:13
Documents
49
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-10q_20160930.htm 10-Q 1384065
2 EX-10.1 nktr-ex101_8.htm EX-10.1 543427
3 EX-31.1 nktr-ex311_9.htm EX-31.1 16069
4 EX-31.2 nktr-ex312_7.htm EX-31.2 16081
5 EX-32.1 nktr-ex321_6.htm EX-32.1 7778
  Complete submission text file 0001564590-16-027488.txt   4896756

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nktr-20160930.xml EX-101.INS 703827
7 XBRL TAXONOMY EXTENSION SCHEMA nktr-20160930.xsd EX-101.SCH 45568
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20160930_cal.xml EX-101.CAL 44520
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20160930_def.xml EX-101.DEF 101583
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20160930_lab.xml EX-101.LAB 300957
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20160930_pre.xml EX-101.PRE 206368
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 161973440
SIC: 2834 Pharmaceutical Preparations